The IAH1 Knockout SK-HEP-1 Polyclonal Cells represent a CRISPR/Cas9-mediated gene-disrupted population derived from the human hepatic adenocarcinoma SK-HEP-1 cell line. This product targets the IAH1 locus to create a loss-of-function model for investigating the biological roles of this serine esterase. The polyclonal format comprises a heterogeneous pool of cells bearing various CRISPR-induced mutations, offering a robust system for functional studies while avoiding artifacts associated with single-cell clones. Researchers can employ these knockout cells to probe IAH1-dependent ester metabolism, signaling interactions, and contributions to hepatocellular carcinoma biology.
SK-HEP-1 is a widely utilized human hepatic adenocarcinoma cell line that exhibits both epithelial and endothelial-like characteristics. Originally isolated from a liver cancer patient, these cells are recognized for their atypical features, including expression of endothelial markers and angiogenic capacity. This dual phenotype makes SK-HEP-1 a valuable model for studying not only hepatocellular carcinoma but also tumor-endothelial interactions and processes such as vascular mimicry. The cells?? metabolic profile further renders them suitable for investigating lipid metabolism and esterase function in a cancer context.
The IAH1 gene encodes a serine esterase that catalyzes the hydrolysis of isoamyl acetate and other short-chain acyl esters, producing isoamyl alcohol and acetic acid. The generated acetic acid can be converted to acetyl-CoA, thereby linking IAH1 activity directly to the acetyl-CoA metabolic process and broader lipid metabolism. In this capacity, IAH1 acts upstream of acetyl-CoA-dependent pathways, including the tricarboxylic acid cycle, fatty acid synthesis, and histone acetylation. Although specific upstream regulators of IAH1 remain to be identified, its enzymatic function positions it as a modulator of intracellular ester and acetyl-CoA levels, with potential influences on energy homeostasis and biosynthetic processes.
In the SK-HEP-1 liver cancer model, disruption of IAH1 offers a unique window into the role of esterases in tumor metabolism and progression. Given the hepatic origin and endothelial-like properties of the host cells, IAH1 knockout may affect lipid utilization, acetyl-CoA availability, and pathways essential for cancer cell proliferation and angiogenesis. This model enables investigation of whether esterase activity contributes to the metabolic flexibility required for tumor growth under nutrient stress, and how loss of IAH1 impacts acetyl-CoA-dependent phenomena such as histone modification and gene expression. Moreover, the endothelial features permit exploration of esterase function in vascular mimicry and tumor-host interactions.
These polyclonal knockout cells are ideally suited for a range of research applications, including esterase functional assays using fluorogenic substrates to quantify enzymatic activity, gene expression analysis via RT-qPCR and western blotting, and metabolite profiling through HPLC or LC-MS to track isoamyl alcohol, acetic acid, and acetyl-CoA dynamics. They also serve as a platform for drug metabolism studies, particularly for ester-containing prodrugs or xenobiotics, and for enzyme kinetics investigations. The polyclonal nature ensures experimental reproducibility and reduces clonal variability, making them a reliable tool for screening and mechanistic studies. For additional details or inquiries, please contact Ascent Research.
